HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues.

Abstract
It has been proposed that the enhanced metabolic activity of tumor cells is accompanied by an increased expression of facilitative hexose transporters (GLUTs). However, a previous immunohistochemical analysis of GLUT1 expression in 154 malignant human neoplasms failed to detect the GLUT1 isoform in 87 tumors. We used 146 normal human tissues and 215 tumor samples to reassess GLUT1 expression. A similar number of samples were used to compare the expression of GLUT2-6 and 9. The classical expression of GLUT1-5 in different normal human tissues was confirmed, however, we were unable to detect GLUT2 in human pancreatic islet cells. GLUT6 was principally detected in testis germinal cells and GLUT9 was localized in kidney, liver, heart, and adrenal. In tumor samples, GLUT1, 2, and 5 were the main transporters detected. GLUT1 was the most widely expressed transporter, however, 42% of the samples had very low-to-negative expression levels. GLUT2 was detected in 31% of the samples, being mainly expressed in breast, colon, and liver carcinoma. GLUT5 was detected in 27% of breast and colon adenocarcinoma, liver carcinoma, lymphomas, and testis seminoma samples. In situ RT-PCR and ultrastructural immunohistochemistry confirmed GLUT5 expression in breast cancer. GLUT6 and 9 are not clearly over-expressed in human cancer. The extensive expression of GLUT2 and 5 (glucose/fructose and fructose transporters, respectively) in malignant human tissues indicates that fructose may be a good energy substrate in tumor cells. Our functional data obtained in vitro in different tumor cells support this hypothesis. Additionally, these results suggest that fructose uptake could be used for positron emission tomography imaging and, may possibly represent a novel target for the development of therapeutic agents in different human cancers.
AuthorsAlejandro Godoy, Viviana Ulloa, Federico Rodríguez, Karin Reinicke, Alejandro J Yañez, María de los Angeles García, Rodolfo A Medina, Mónica Carrasco, Sofía Barberis, Tamara Castro, Fernando Martínez, Ximena Koch, Juan Carlos Vera, María Teresa Poblete, Carlos D Figueroa, Bruno Peruzzo, Fernando Pérez, Francisco Nualart
JournalJournal of cellular physiology (J Cell Physiol) Vol. 207 Issue 3 Pg. 614-27 (Jun 2006) ISSN: 0021-9541 [Print] United States
PMID16523487 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2006 Wiley-Liss, Inc.
Chemical References
  • Glucose Transport Proteins, Facilitative
Topics
  • Animals
  • Biopsy
  • Breast (metabolism, pathology, ultrastructure)
  • Gene Expression Regulation, Neoplastic
  • Glucose Transport Proteins, Facilitative (genetics, metabolism)
  • Health
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Mice
  • Microscopy, Immunoelectron
  • Neoplasms (genetics, metabolism, pathology, ultrastructure)
  • Organ Specificity
  • Rats
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: